US-based drugmaker Pfizer and Indian biotechnology major Bicon today said they have agreed to end their alliance to sell insulin and insulin analog products made by the Indian company.
Forty Indians entered the billionaires' club in the pandemic-stricken 2020 to take the number of those in the coveted list to 177 people, a report said on Tuesday. Mukesh Ambani continued to be the wealthiest Indian with a networth of $83 billion. The head of Reliance Industries witnessed a 24 per cent jump in fortunes and climbed up one spot to be the eighth richest globally, as per the Hurun Global Rich List. Gautam Adani from Gujarat, who has had a spectacular rise in fortunes in the last few years, saw his wealth almost doubling to $32 billion in 2020 and climbed 20 places to be the 48th richest person globally and the second wealthiest Indian.
Ajit Mishra, vice president, research, Religare Broking, answers your stockmarket queries.
Her research was focused on urban development, macro-economic reforms, industrial development, and social sector development issues in India.
Kiran Mazumdar-Shaw talks to Nikita Puri about her book Mythbreaker.
A video of the CEO dancing along with her staffers is winning the Internet and encouraging other leaders to make workplaces happier.
Of the total scrips traded, 1,998 advanced, 631 declined and 184 remained unchanged.
Ajit Mishra, vice president, research, Religare Broking, answers your queries.
The biggest spender was Tata Motors, with Rs 4,224.6 crore assigned under the R&D head.
Biocon CMD Kiran Mazumdar-Shaw has been named in the world's top 100 'effective and talented' people by US-based 'Scientific American' magazine.
'We are going to be overwhelmed by the need for hospital beds. There are simply not enough beds in government hospitals.' 'We will need a large number of medical professionals and without the private sector's involvement, the government won't be able to expand capacity.'
The sector earns a little more than half of its revenue from exports.
Arundhati Bhattacharya, the chairperson of country's largest bank SBI, has been named as the most-powerful woman in business in India by Fortune magazine.
Ajit Mishra answers reader queries on the stock market.
Fund managers said investors remained positive on the pharma manufacturing activity in India, which further strengthened during the Covid-19 period, on account of restrictions imposed on pharma imports from China.
Gautam Adani, who is diversifying into many businesses, saw a 48 per cent rise in his wealth to Rs 1.40 lakh crore and moved up two places in rankings to being the fourth richest Indian. Hinduja Brothers and HCL's Shiv Nadar were ranked 2nd and 3rd. Wipro's Azim Premji slipped two places to fifth place.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
'Kindly advise about the following stocks. Can I hold or exit?'
Proxy advisory firms say the praise on Twitter was uncalled for.
Pharmaceuticals, along with software and services, also added the most new entrants on the rich list 2018.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
These women are building billion-dollar brands, calling the shots in the financial markets, and crisscrossing the globe to broker international agreements and provide aid, the magazine noted
Karnataka has attracted 18 new biotechnology firms and a total investment of $400 million (Rs 1,800 crore), including Rs 750 crore (Rs 7.5 billion) from India's biggest biotech firm Biocon, in the last 12 months.
The women on the 17th annual Forbes Power List hail from 30 countries and were born across four generations.
Yet another achievement is added to PeeCee's growing list.
Since UK referendum outcome to exit European Union last Friday, 32 companies have hit record highs.
Biocon chairperson and managing director Kiran Mazumdar-Shaw is in a firefighting mode, as the company she founded was forced to call off a blockbuster deal with global pharmaceutical major Pfizer.
Indian women have education, inspiration and perspiration -- but not enough employment, points out Mahesh Vyas.
Take the Rediff Biz Quiz and find out how much you know about India and its biotech firms.
Beyond her avatar as the head of a multi-crore biotech company, Kiran Mazumdar-Shaw is a powerful voice of change for the city she lives in.
Auto, pharma, IT, chemicals among sectors with significant reliance on UK and European nations with Tata Motors, Motherson Sumi, Tata Steel, TCS, Wipro, Infosys and Tech M among key names.
'If the government doesn't subsidise, it would be a huge setback in the fight against COVID-19'
Testing only those with symptoms is not such a great idea. A lot of asymptomatic people are also positive. Its also important to do some amount of random testing in the clusters. You need to do lot more testing. The more you test, the more positives you get. Only redeeming feature is that the number of those getting into ICU or dying is not huge, she said.
Six Indian women have made it to Asia's most powerful women list released by Forbes.
India-born PepsiCo chief Indra Nooyi figures among the top10 in 2013.
The drug regulator recently asked some domestic companies to cut prices of insulin while MNCs, which are major players, are allowed to set their own price for the drug.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Kiran Mazumdar-Shaw points out how the adoption of information and communication technologies can provide India with a very effective health care tool.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances